This inventor holds 1 USPTO granted patent. Top assignees: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Medigene Ag. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 168 
1 out of 48 
Years Active: 2012
Title: Achim Krüger: Innovator in Tumor Treatment
Introduction
Achim Krüger is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of tumors. His innovative work has led to the development of a specific anti-L1 antibody that holds promise for cancer therapy.
Latest Patents
Achim Krüger holds 1 patent related to his invention titled "Treatment of tumors using specific anti-L1 antibody." This patent focuses on the anti-L1 monoclonal antibody 9.3, along with related antibodies or binding molecules, and their applications in tumor treatment.
Career Highlights
Throughout his career, Achim has worked with prominent organizations such as the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and Medigene AG. His experience in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Achim has collaborated with esteemed colleagues, including Daniela Kelm and Peter Altevogt. These partnerships have enriched his research and fostered innovation in the field of tumor treatment.
Conclusion
Achim Krüger's work exemplifies the impact of innovative research in medicine. His contributions to tumor treatment through the development of specific antibodies highlight the importance of continued exploration in this vital area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile